Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Fish and Richardson
Boehringer Ingelheim
Argus Health
Express Scripts

Generated: June 25, 2017

DrugPatentWatch Database Preview

Ephedrine sulfate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ephedrine sulfate and what is the scope of ephedrine sulfate patent protection?

Ephedrine sulfate
is the generic ingredient in three branded drugs marketed by Akorn Inc, Par Sterile Products, and Flamel Ireland Ltd, and is included in three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are sixty-seven drug master file entries for ephedrine sulfate. Three suppliers are listed for this compound.

Summary for Generic Name: ephedrine sulfate

Drug Master File Entries: see list67
Suppliers / Packagers: see list3
Bulk Api Vendors: see list44
Clinical Trials: see list737
Patent Applications: see list5,487
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ephedrine sulfate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Sterile Products
ephedrine sulfate
SOLUTION;IV (INFUSION)208943-001Jan 27, 2017RXNoNo► Subscribe► Subscribe
Flamel Ireland Ltd
ephedrine sulfate
SOLUTION;INTRAVENOUS208289-001Apr 29, 2016APRXYesYes► Subscribe► Subscribe
Akorn Inc
ephedrine sulfate
SOLUTION;INTRAVENOUS208609-001Mar 1, 2017APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus